Heffernan Mark
Insider CIK 1632439 · NVET Chief Executive Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVET Nexvet Biopharma plc | D To issuer deriv | 2017-07-31 | 2017-08-02 | 50,000 | $6.60 | $330.0K | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer deriv | 2017-07-31 | 2017-08-02 | 106,929 | $6.60 | $705.7K | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer deriv | 2017-07-31 | 2017-08-02 | 4,833 | $6.60 | $31.9K | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer deriv | 2017-07-31 | 2017-08-02 | 52,040 | $0.37 | $19.3K | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer deriv | 2017-07-31 | 2017-08-02 | 100,000 | — | $0 | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer deriv | 2017-07-31 | 2017-08-02 | 9,203 | $6.60 | $60.7K | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer | 2017-07-31 | 2017-08-02 | 243,587 | $6.72 | $1.64M | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | D To issuer | 2017-07-31 | 2017-08-02 | 109,810 | $6.72 | $737.9K | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2017-07-01 | 2017-07-05 | 25,000 | — | $0 | 50,000 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2017-07-01 | 2017-07-05 | 35,643 | — | $0 | 106,929 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2017-07-01 | 2017-07-05 | 25,000 | $0.13 | $3.3K | 74,167 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2017-07-01 | 2017-07-05 | 35,643 | $0.13 | $4.6K | 109,810 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-09-05 | 2016-09-07 | 142,572 | — | $0 | 142,572 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-07-01 | 2016-07-01 | 25,000 | — | $0 | 75,000 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2016-07-01 | 2016-07-01 | 4,833 | — | $0 | 4,833 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2016-07-01 | 2016-07-01 | 4,833 | $0.13 | $628 | 24,167 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2016-07-01 | 2016-07-01 | 25,000 | $0.13 | $3.3K | 49,167 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-11-23 | 2015-11-24 | 7,250 | — | $0 | 9,666 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2015-11-23 | 2015-11-24 | 7,250 | $0.13 | $943 | 19,334 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-11-20 | 2015-11-20 | 9,204 | — | $0 | 9,203 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise | 2015-11-20 | 2015-11-20 | 9,204 | $0.13 | $1.2K | 243,587 | SEC↗ |
| NVET Nexvet Biopharma plc | A Award deriv | 2015-09-03 | 2015-09-08 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVET Nexvet Biopharma plc | M Exercise deriv | 2015-08-20 | 2015-08-20 | 4,834 | — | $0 | 16,916 | SEC↗ |
| NVET Nexvet Biopharma plc | A Award | 2015-08-20 | 2015-08-20 | 4,834 | $0.13 | $628 | 12,084 | SEC↗ |
| NVET Nexvet Biopharma plc | A Award | 2015-06-08 | 2015-06-10 | 7,250 | $0.13 | $943 | 7,250 | SEC↗ |
| NVET Nexvet Biopharma plc | A Award deriv | 2015-05-18 | 2015-05-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVET Nexvet Biopharma plc | C Conversion deriv | 2015-02-10 | 2015-02-10 | 4,424 | — | $0 | 0 | SEC↗ |
| NVET Nexvet Biopharma plc | C Conversion | 2015-02-10 | 2015-02-10 | 4,424 | — | $0 | 234,383 | SEC↗ |